Johns Hopkins University scientists have deciphered the genetic code for a rare type of pancreatic cancer — neuroendocrine or islet cell tumor — that Apple CEO Steve Jobs told the world he’d been diagnosed with back in 2004. The discovery explains many of the cancer’s troubling, highly variable properties and suggests new treatment approaches. “This is big news,” said tech analyst Rob Enderle. “I suspect that not only could this discovery impact the market for Apple’s stock, but that it could also have a very positive impact on genetic and pancreatic tumor research generally.”
Tell me they did it with an I-Pad app and I'll be impressed!
Loading ...
Scientists Crack Genetic Code for Rare Cancer That Beset Steve Jobs
Posted by: Mike Martin January 20, 2011 12:00 PMJohns Hopkins University scientists have deciphered the genetic code for a rare type of pancreatic cancer — neuroendocrine or islet cell tumor — that Apple CEO Steve Jobs told the world he’d been diagnosed with back in 2004. The discovery explains many of the cancer’s troubling, highly variable properties and suggests new treatment approaches. “This is big news,” said tech analyst Rob Enderle. “I suspect that not only could this discovery impact the market for Apple’s stock, but that it could also have a very positive impact on genetic and pancreatic tumor research generally.”